05/09/2026
🩸 PRP has traditionally started with a blood draw. What if it started in the bone instead?
A new pilot study is taking a closer look at intraosseous-derived PRP, asking whether the source of the biologic material could influence its regenerative properties.
Early findings from paired samples suggest differences in VEGF, IL-10, TGF-beta, SDF-1 and other signaling molecules compared with conventional peripheral-blood PRP.
But there’s an important caveat: this was a five-patient characterization study with no clinical outcomes.
Could this be a new direction for orthobiologics?
👉 Read the full story to explore the science behind the approach: https://www.painmedicinenews.com/a/NT0BAA/f